BZAI Legal Overhang: $20M Bogus Deal Claim, Oct. 5 Deadline

For BZAI shareholders and trading desks, the class action converts an accounting-fraud narrative into a deadline-driven event. The market reaction to the April 28, 2026 Pelican Way Research report reportedly hit the stock, and the litigation now layers legal uncertainty onto revenue-quality and dilution concerns raised by the short seller.

Faruqi & Faruqi, LLP alerted investors through a September 26, 2026 press release that an October 5, 2026 deadline is approaching to seek lead plaintiff in a federal securities class action against Blaize Holdings, Inc. (Nasdaq: BZAI). The proposed class period spans July 18, 2025 through April 28, 2026. Because this notice originates from a plaintiff-side law firm and is distributed through newswire feeds, it functions as a solicitation and a legal claim narrative rather than independent reporting; the underlying allegations have not been proven or adjudicated.

“

Faruqi & Faruqi, LLP alerted investors through a September 26, 2026 press release that an October 5, 2026 deadline is approaching to seek lead plaintiff in a federal securities class action against Blaize Holdings, Inc.

According to the announcement, the complaint asserts that Blaize and its executives violated federal securities laws by making false or misleading statements and failing to disclose material facts. Specifically, the suit claims that Blaize announced transactions with entities wholly unequipped to conduct meaningful business in order to create an appearance of growth, and that the company improperly recognized revenue. These are classic securities-fraud theories: the first attacks the substance of disclosed business activity, while the second attacks the accounting treatment of that activity. If either theory survives, the central question will be whether the alleged misstatements were material and whether they caused investor losses under the fraud-on-the-market presumption.

The most concrete allegation centers on a short-seller report. On April 28, 2026, Pelican Way Research published a report titled "Blaize AI: Running Up The Share Price Based on a Seemingly Bogus Deal, Conveniently Timed for Massive Dilution." The report, as summarized in the Faruqi notice, alleged that Blaize had artificially boosted its share price through a deal with NeoTensr, a counterparty only about four months old. The report claimed NeoTensr's website displayed products that appeared to be photoshopped to add the Blaize logo, that NeoTensr was incorporated in late December 2025 with only about $2 million in startup capital, and that it was therefore inconceivable for Blaize to have achieved $20 million in revenue from a NeoTensr order in Q4 2025. The notice states that Blaize's stock price fell on the news, although it does not provide the magnitude of the decline.

For investors, the October 5, 2026 deadline is the cutoff to move for lead plaintiff under the Private Securities Litigation Reform Act. The lead plaintiff typically has the largest financial interest in the relief sought and is often an institutional investor. The lead plaintiff selects lead counsel and controls the direction of the litigation. Investors who purchased Blaize securities during the class period and suffered losses do not need to become lead plaintiff to participate in any eventual class recovery, but they must file a motion by the deadline if they want to seek that role. Faruqi is actively recruiting potential lead plaintiffs and directs investors to contact securities litigation partner James (Josh) Wilson at 877-247-4292 or 212-983-9330, extension 1310.